Expression of ZEB1 and Its Relationship with Prognosis in Breast Cancer

Xingen Wang,Yumin Zhou

2016-01-01

Abstract:Objective To detect the expression of zinc finger E-box-binding protein 1(ZEB1)in different tissues ofbreast tumors and explore its relationship with the clinicopathological features and progress in breast cancer. Methods ZEB1 was detected by immunohistochemistry in the sample tissues, including 62 cases of invasive breast cancer, 14 cases of ductalcarcinoma in situ, 36 cases of lymph node metastatis carcinoma, and 24 cases of carcinoma adjacent tissues. At the same time,the ZEB1 expression was also detected by using the tissue microarray method in the sample tissues of 150 cases of invasivebreast carcinoma. Results The rates of expression of ZEB1 in invasive breast carcinoma, ductal carcinoma in situ, lymphnode metastatic carcinoma, and adjacent tissue of tumor were 17.7%, 0, 41.7%, and 4.2% respectively. There was nocorrelation between ZEB1 and the age tumour size, ER, PR, and HER2 respectively, but the higher ZEB1 expression wasdetected in histology type carcinoma and in patients who had lymph node metastasis. The ZEB1 expression was significantlyhigher in invasive lobular carcinoma than in invasive ductal carcinoma. The survival analysis showed that the patients in theZEB1 positive group had worse prognosis and lower survival rate than the patients in the negative group. Conclusion ZEB1 not only can serve as a predictor of breast cancer with more aggressive and poor prognosis, but also can be a potential biologicaltarget for targeted therapy.